Medicine
Nafcillin 2 g/100 mL injection
Nafcillin 2 g/100 mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store at or below -20°C/-4°F.
Key facts
- Active ingredient (INN)
- Nafcillin
- Brand
- Sold under the generic name
- Strength
- 2 g/100 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 100 mL
- Manufacturer
- Baxter Healthcare
- Origin register
- US FDA, United States
- Storage
- Store at or below -20°C/-4°F.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01CF06 Nafcillin
- HS code (indicative)
- 3004.10Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 October 1989
- Identifiers
- RxCUI 1721458, 1721460DailyMed set ID cd2d18c5-95a2-4fb4-bd8b-b5d39e2da416NDC 0338-1019Application NDA050655
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 mL in 1 bag | 0338-1019-48 | Baxter Healthcare | 31 October 1989 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 11 October 1965 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Nafcillin
Clinical summary
Nafcillin is a penicillin-class antibacterial indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. It is available as powder for injection and injection for intravenous and intramuscular use. MedsAcross supplies Nafcillin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NafcillinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- NAFCILLIN prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Nafcillin 2 g/100 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.